Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

EFTREFTR
9 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in eFFECTOR Therapeutics, Inc.

TWO SIGMA INVESTMENTS, LP previously held 0 shares of EFTR (eFFECTOR Therapeutics, Inc.), worth $0 as of 2024-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$117,000

Total Shares Change

-14,122

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$0.04
0
2024-Q2
New
11,115
-
$3,2240.0%$0.29
21
2023-Q3
Exited
0
-100.0%
$00.0%$15.00
0
2023-Q2
New
81,558
-
$67,7090.0%$18.99
29
2023-Q1
Exited
0
-100.0%
$00.0%$8.74
0
2022-Q4
Decreased
38,577
-18.3%
$16,4960.0%$10.69
0
2022-Q3
New
47,223
-
$27,0000.0%$14.25
27
2022-Q1
Exited
0
-100.0%
$00.0%$101.25
0
2021-Q4
New
14,122
-
$117,0000.0%$194.25
30

Other major holders of EFTR: Blackstone Inc., Carlyle Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used